Amgen Inc. (AMGN) Financials
AMGN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 97.2 billion | 90.9 billion |
| 2023-09-30 | 90.5 billion | 82.9 billion |
| 2023-06-30 | 90.3 billion | 83.5 billion |
| 2023-03-31 | 88.7 billion | 83.4 billion |
AMGN Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 289.0 million | 198.0 million |
| 2023-09-30 | 2.8 billion | -149.0 million |
| 2023-06-30 | 3.8 billion | 689.0 million |
| 2023-03-31 | 720.0 million | ? |
AMGN Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 767.0 million |
| 2023-09-30 | 1.7 billion |
| 2023-06-30 | 1.4 billion |
| 2023-03-31 | 2.8 billion |
AMGN Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 10.9 billion | - | - |
| 2023-09-30 | 34.7 billion | - | - |
| 2023-06-30 | 34.2 billion | 59.4 billion | - |
| 2023-03-31 | 31.6 billion | 60.8 billion | - |
AMGN Shares Outstanding
AMGN Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 249.0 million | 1.5 billion | 1.6 billion | 647.0 million |
| 2023-09-30 | 248.0 million | 1.1 billion | 1.4 billion | - |
| 2023-06-30 | 271.0 million | 1.1 billion | 1.3 billion | - |
| 2023-03-31 | 344.0 million | 1.1 billion | 1.3 billion | - |
AMGN Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 8.2 billion | 3.1 billion |
| 2023-09-30 | 6.9 billion | 1.8 billion |
| 2023-06-30 | 7.0 billion | 1.8 billion |
| 2023-03-31 | 6.1 billion | 1.7 billion |
AMGN
List: Contenders
Price: $271.67
Dividend Yield: 0.03%
Forward Dividend Yield: 3.31%
Payout Ratio: 72.00%
Dividend Per Share: 9.00 USD
Earnings Per Share: 12.48 USD
P/E Ratio: 23.13
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 1.7 million
Ebitda: 3.6 billionMarket Capitalization: 142.0 billion
Average Dividend Frequency: 4
Years Paying Dividends: 14
DGR3: 9.10%
DGR5: 9.13%
DGR10: 13.83%